- We remain positive on Riverstone’s growth outlook, premised on the recovery of global semiconductor sales as well as its differentiated exposure within the healthcare specialty gloves industry, which commands better profitability than generic gloves.
Outlook of glove sector
- - Read this at SGinvestors.io -
- - Read this at SGinvestors.io -
A differentiated glove player.
- Unlike other OEM manufacturers, Riverstone is the sole glove player that remained profitable even during the industry downcycle in 2022-2023. This is predicated on Riverstone’s differentiated product offerings, i.e. cleanroom and healthcare specialty gloves, which do not experience oversupply.
- Other differentiating factors include its ability to maintain a consistent dividends payout, offering an attractive yield of 5%.
Earnings estimate & target price
- Read more at SGinvestors.io.
Singapore Research RHB Securities Research | https://www.rhbgroup.com/ 2025-01-09
Previous report by RHB:
2024-11-13 Riverstone - Growth Remains Intact; Maintain BUY.
Price targets by 3 other brokers at Riverstone Target Prices.
Listing of research reports at Riverstone Analyst Reports.
Relevant links:
Riverstone Share Price History,
Riverstone Announcements,
Riverstone Dividends & Corporate Actions,
Riverstone News Articles
